Advertisement

Related Videos

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Welcome and Introduction to Vi3C

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Feb
10
Today In Oncology
HPV Testing During Cervical Cancer Screening Potential Convenient and Noninvasive Method
Guidelines Harmonize Pan-Tumor Pathologic Response to Neoadjuvant Therapy
Tissue-Free ctDNA and Outcomes in Patients With Colorectal Cancer Receiving FOLFOX-Based Adjuvant Therapy
Ultraprocessed Food Associated With Increased Mortality Risk in Cancer Survivors
A Paradigm Shift In Treating Adult AML?
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo